| Donald E Cutlip, MD | |
|
Beth Israel Deaconess Med Ctr, 330 Brookline Ave., Es-217, Boston, MA 02215 | |
| (617) 667-7455 | |
| Not Available |
| Full Name | Donald E Cutlip |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 45 Years |
| Location | Beth Israel Deaconess Med Ctr, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396777827 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Beth Israel Deaconess Hospital Plymouth | Plymouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).
Republican legislators and representatives of several minority health advocacy groups on Tuesday at a House Energy and Commerce Health Subcommittee hearing raised concerns over several measures within a proposed bill (HR 3014) intended to reduce racial and ethnic disparities in the U.S. health care system, CQ HealthBeat reports.
In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
› Verified 3 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918 |
News Archive
Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).
Republican legislators and representatives of several minority health advocacy groups on Tuesday at a House Energy and Commerce Health Subcommittee hearing raised concerns over several measures within a proposed bill (HR 3014) intended to reduce racial and ethnic disparities in the U.S. health care system, CQ HealthBeat reports.
In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
› Verified 3 days ago
| Entity Name | Jordan Physician Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538145131 PECOS PAC ID: 1254321086 Enrollment ID: O20040514000167 |
News Archive
Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).
Republican legislators and representatives of several minority health advocacy groups on Tuesday at a House Energy and Commerce Health Subcommittee hearing raised concerns over several measures within a proposed bill (HR 3014) intended to reduce racial and ethnic disparities in the U.S. health care system, CQ HealthBeat reports.
In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
› Verified 3 days ago
| Entity Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).
Republican legislators and representatives of several minority health advocacy groups on Tuesday at a House Energy and Commerce Health Subcommittee hearing raised concerns over several measures within a proposed bill (HR 3014) intended to reduce racial and ethnic disparities in the U.S. health care system, CQ HealthBeat reports.
In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald E Cutlip, MD 165 Thorndike St, Brookline, MA 02446-5818 Ph: (617) 667-7455 | Donald E Cutlip, MD Beth Israel Deaconess Med Ctr, 330 Brookline Ave., Es-217, Boston, MA 02215 Ph: (617) 667-7455 |
News Archive
Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).
Republican legislators and representatives of several minority health advocacy groups on Tuesday at a House Energy and Commerce Health Subcommittee hearing raised concerns over several measures within a proposed bill (HR 3014) intended to reduce racial and ethnic disparities in the U.S. health care system, CQ HealthBeat reports.
In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.
› Verified 3 days ago
Kaitlyn My-tu Lam, MBBS Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |